Literature DB >> 4151695

Beta-adrenergic receptor blocking drugs in angina pectoris.

B N Prichard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4151695     DOI: 10.2165/00003495-197407010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  82 in total

1.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

2.  Haemodynamic effects of dextro-propranolol in acute myocardial infarction.

Authors:  D Bennet; R Balcon; J Hoy; E Sowton
Journal:  Thorax       Date:  1970-01       Impact factor: 9.139

3.  Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.

Authors:  A J Wasserman; J D Proctor; F J Allen; V E Kemp
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Jan-Feb

4.  Propranolol in the office treatment of angina pectoris.

Authors:  B J Harley; R O Davies
Journal:  Can Med Assoc J       Date:  1968-09-28       Impact factor: 8.262

5.  Propranolol in patients with angina pectoris.

Authors:  R E Gianelly; R H Goldman; B Treister; D C Harrison
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

6.  Propranolol in the therapy of angina pectoris.

Authors:  P M Gillam; B N Prichard
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

Review 7.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

Review 8.  Activation and blockade of beta adrenoceptors in common cardiac disorders.

Authors:  J W Black; B N Prichard
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

9.  Myocardial vascular reactivity after beta-adrenergic blockade.

Authors:  J R Parratt; J Grayson
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

10.  Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.

Authors:  G Sandler; G A Clayton
Journal:  Br Med J       Date:  1970-05-16
View more
  18 in total

1.  Letter: Misleading drug advertising.

Authors:  B N Prichard
Journal:  Br Med J       Date:  1975-05-03

2.  Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1977

Review 3.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

Review 4.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

Review 5.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

6.  Effect of diltiazem and propranolol on myocardial ischaemia during unrestricted daily life in patients with effort-induced chronic stable angina pectoris.

Authors:  N S Khurmi; M J O'Hara; M J Bowles; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 7.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  Drug treatment of chronic stable angina pectoris.

Authors: 
Journal:  Br Med J       Date:  1978-02-25

9.  Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.

Authors:  D C Harrison
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.